We are live on ! Find out more
PHS

PFM Health Sciences Portfolio holdings

AUM $1.1B
1-Year Est. Return 57.92%
This Fund
S&P 500
This Quarter Est. Return
+18.38%
1 Year Est. Return
+57.92%
3 Year Est. Return
+183.93%
5 Year Est. Return
+283%
10 Year Est. Return
+2,507.28%
AUM
$3.71B
AUM Growth
-$281M
Cap. Flow
-$830M
Cap. Flow %
-22.37%
Top 10 Hldgs %
31.98%
Holding
127
New
29
Increased
29
Reduced
22
Closed
37

Top Buys

Rank Stock Value
1
KITE
Kite Pharma, Inc.
KITE
+$73.3M
2
MCK icon
McKesson
MCK
+$66.4M
3
NOW icon
ServiceNow
NOW
+$60.6M
4
DXC icon
DXC Technology
DXC
+$60M
5
MSFT icon
Microsoft
MSFT
+$58M

Top Sells

Rank Stock Value
1
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$125M
2
MRVL icon
Marvell Technology
MRVL
+$118M
3
BIIB icon
Biogen
BIIB
+$102M
4
WFT
Weatherford International plc
WFT
+$102M
5
CSC
Computer Sciences
CSC
+$98M

Sector Composition

Rank Sector Weight
1 Healthcare 40.08%
2 Technology 13.76%
3 Consumer Discretionary 5.54%
4 Communication Services 4.09%
5 Financials 3.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ICLR icon
51
Icon
ICLR
$12.8B
$21.5M 0.58%
220,190
-67,878
-24% -$6M
PYPL icon
52
PayPal
PYPL
$49.5B
$20.1M 0.54%
375,399
-130,111
-26% -$6.39M
MRVL icon
53
Marvell Technology
MRVL
$174B
$19.9M 0.54%
1,205,837
-7,273,785
-86% -$118M
XYZ
54
Block Inc
XYZ
$45.9B
$19.6M 0.53%
834,542
+44,395
+6% +$918K
BLK icon
55
Blackrock
BLK
$164B
$19.4M 0.52%
+45,942
New +$18.3M
AAPL icon
56
Apple
AAPL
$4.89T
$19.3M 0.52%
535,232
-472,896
-47% -$17.5M
KURA icon
57
Kura Oncology
KURA
$922M
$18.9M 0.51%
2,037,493
+4,264
+0.2% +$38.8K
RXDX
58
DELISTED
Ignyta, Inc.
RXDX
$18.8M 0.51%
+1,820,496
New +$14.8M
ZEN
59
DELISTED
ZENDESK INC
ZEN
$15.3M 0.41%
+550,532
New +$15.1M
VMC icon
60
Vulcan Materials
VMC
$36.3B
$15M 0.41%
118,745
– –
BKNG icon
61
Booking.com
BKNG
$138B
$14.9M 0.4%
+198,875
New +$14.6M
NVDA icon
62
NVIDIA
NVDA
$5.01T
$14.7M 0.4%
+4,077,960
New +$13M
MMSI icon
63
Merit Medical Systems
MMSI
$4.43B
$14.7M 0.4%
+384,901
New +$12.9M
BMRN icon
64
BioMarin Pharmaceuticals
BMRN
$11.5B
$13.9M 0.37%
153,018
-830,108
-84% -$75.5M
TREE icon
65
LendingTree
TREE
$544M
$12.3M 0.33%
+71,685
New +$10.8M
HRC
66
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
$11.7M 0.32%
+147,304
New +$11.1M
EVH icon
67
Evolent Health
EVH
$475M
$11.4M 0.31%
448,178
-32,244
-7% -$775K
XENT
68
DELISTED
Intersect ENT, Inc
XENT
$11M 0.3%
394,338
+254,727
+182% +$5.77M
CSII
69
DELISTED
Cardiovascular Systems, Inc.
CSII
$11M 0.3%
341,216
-100,445
-23% -$3.06M
ESPR
70
DELISTED
Esperion Therapeutics
ESPR
$9.9M 0.27%
+213,980
New +$7.87M
JNCE
71
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
$9.79M 0.26%
698,159
+199,445
+40% +$4.27M
ALDR
72
DELISTED
Alder Biopharmaceuticals
ALDR
$9.55M 0.26%
834,191
-210,990
-20% -$3.9M
VYGR icon
73
Voyager Therapeutics
VYGR
$187M
$7.64M 0.21%
853,125
-642,676
-43% -$6.47M
EVHC
74
DELISTED
Envision Healthcare Holdings Inc
EVHC
$6.73M 0.18%
+107,370
New +$6.19M
RGNX icon
75
Regenxbio
RGNX
$623M
$5.36M 0.14%
271,603
-526,644
-66% -$10.2M
1 2
3
4 5

Similar funds

DAM
Delta Asset Management Memphis, Tennessee $1.1B AUM 14.89% 1-Year Est. Return
MAM
Mark Asset Management New York $1.1B AUM 43.79% 1-Year Est. Return
LCM
Legato Capital Management San Francisco, California $1.1B AUM 61.65% 1-Year Est. Return
PRS
Pinkerton Retirement Specialists Coeur D Alene, Idaho $1.1B AUM 30.57% 1-Year Est. Return
DAM
DLD Asset Management New York $1.1B AUM 4.68% 1-Year Est. Return
KCM
Khrom Capital Management Miami Beach, Florida $1.09B AUM 14.82% 1-Year Est. Return
CF
Corebridge Financial Houston, Texas $1.09B AUM 1.85% 1-Year Est. Return
MIA
MMBG Investment Advisors Miami, Florida $1.09B AUM 30.96% 1-Year Est. Return

PFM Health Sciences's Q2 2017 Portfolio in Review

As of Q2 2017, PFM Health Sciences held 127 positions worth $3.71B, down 7% from $3.99B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

PFM Health Sciences withdrew a net $830M in Q2 2017, closing 37 positions and reducing 22 holdings. Its most notable exit was Jazz Pharmaceuticals, an estimated $125M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 40% of assets, up from 39% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, PFM Health Sciences opened a new position in McKesson worth $72.1M.

  • PFM Health Sciences's largest Q2 2017 buy was McKesson: 438,055 shares worth $72.1M.
  • PFM Health Sciences added most to Kite Pharma, Inc. in Q2 2017, an estimated $73.3M increase.
  • PFM Health Sciences's biggest Q2 2017 reduction was Marvell Technology, cutting an estimated $118M.
  • PFM Health Sciences fully exited Jazz Pharmaceuticals in Q2 2017, selling an estimated $125M.
  • PFM Health Sciences's ten largest holdings make up 32% of its $3.71B portfolio in Q2 2017.
  • PFM Health Sciences opened 29 new positions and closed 37 in Q2 2017.
  • PFM Health Sciences's portfolio value fell 7% quarter-over-quarter to $3.71B.

Based on PFM Health Sciences's 13F filing for Q2 2017, filed 14 Aug 2017.